AnaptysBio, Inc. (ANAB)
57.28
-3.27
(-5.40%)
USD |
NASDAQ |
Mar 05, 16:00
57.28
0.00 (0.00%)
After-Hours: 20:00
AnaptysBio Free Cash Flow : 19.61M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vanda Pharmaceuticals, Inc. | -110.44M |
| Nektar Therapeutics | -190.35M |
| Rigel Pharmaceuticals, Inc. | 75.66M |
| AbbVie, Inc. | 17.82B |
| Esperion Therapeutics, Inc. | -93.29M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 98.00M |
| Cash from Investing (Quarterly) | 73.50M |
| Cash from Financing (Quarterly) | -43.13M |
| Free Cash Flow Per Share (Quarterly) | 3.127 |
| Free Cash Flow to Equity (Quarterly) | 153.81M |
| Free Cash Flow to Firm (Quarterly) | 117.67M |
| Free Cash Flow Yield | 1.14% |